Get the Stockscreener App
125.43
1.65%
-2.10
Pre-market:
125.74
0.31
+0.25%
Molina Healthcare Inc stock is traded at $125.43, with a volume of 2.97M.
It is down -1.65% in the last 24 hours and down -30.89% over the past month.
Molina Healthcare provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states—California, New York, Texas, and Washington—account for over half of its enrollees.
See More
Previous Close:
$127.53
Open:
$128
24h Volume:
2.97M
Relative Volume:
1.69
Market Cap:
$6.45B
Revenue:
$43.41B
Net Income/Loss:
$1.13B
P/E Ratio:
6.1852
EPS:
20.279
Net Cash Flow:
$427.00M
1W Performance:
-30.85%
1M Performance:
-30.89%
6M Performance:
-20.06%
1Y Performance:
-56.21%
1-Day Range:
$125.34
$129.12
1-Week Range:
$123.71
$183.23
52-Week Range:
$123.71
$359.97
Molina Healthcare Inc Stock (MOH) Company Profile
Name
Molina Healthcare Inc
Sector
Industry
Phone
(562) 435-3666
Address
200 OCEANGATE, SUITE 100, LONG BEACH, CA
Compare MOH vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MOH
Molina Healthcare Inc
|
125.43 | 6.56B | 43.41B | 1.13B | 427.00M | 20.28 |
|
UNH
Unitedhealth Group Inc
|
273.22 | 249.74B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
75.70 | 96.18B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
287.81 | 77.56B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
325.64 | 72.28B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
181.30 | 22.79B | 126.36B | 1.30B | 1.55B | 10.67 |
Molina Healthcare Inc Stock (MOH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-24-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-16-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-25-25 | Downgrade | Truist | Buy → Hold |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-25 | Initiated | Morgan Stanley | Overweight |
| Apr-22-25 | Initiated | Bernstein | Outperform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-05-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-28-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-15-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-03-22 | Resumed | JP Morgan | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-26-22 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Nov-22-21 | Resumed | Deutsche Bank | Hold |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Underweight |
| Mar-30-21 | Initiated | Credit Suisse | Outperform |
| Mar-10-21 | Initiated | Mizuho | Buy |
| Feb-19-21 | Resumed | Barclays | Overweight |
| Jan-21-21 | Initiated | Goldman | Neutral |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Resumed | SVB Leerink | Outperform |
| Jun-16-20 | Upgrade | Cowen | Market Perform → Outperform |
| Apr-14-20 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Oct-30-19 | Downgrade | Jefferies | Buy → Hold |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jul-31-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-03-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| May-31-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Apr-30-19 | Reiterated | BofA/Merrill | Underperform |
| Jan-14-19 | Initiated | Stephens | Equal-Weight |
| Jan-08-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-18 | Upgrade | Jefferies | Hold → Buy |
| Oct-12-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-10-18 | Initiated | Evercore ISI | In-line |
| Jun-27-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-22-18 | Upgrade | Jefferies | Hold → Buy |
| Mar-28-18 | Reiterated | Leerink Partners | Outperform |
| Jan-16-18 | Upgrade | JP Morgan | Neutral → Overweight |
View All
Molina Healthcare Inc Stock (MOH) Latest News
Decoding Molina Healthcare Inc (MOH): A Strategic SWOT Insight - GuruFocus
Barclays Lowers Molina Healthcare (MOH) Price Target to $133 | M - GuruFocus
Important Notice to Long-Term Shareholders of Integer - GlobeNewswire
Deutsche Bank Cuts Price Target on Molina Healthcare to $109 From $165, Keeps Hold Rating - marketscreener.com
Barclays Adjusts Price Target on Molina Healthcare to $133 From $164, Maintains Underweight Rating - marketscreener.com
The Analyst Verdict: Molina Healthcare In The Eyes Of 5 Experts - Benzinga
Molina Healthcare (NYSE:MOH) Given New $144.00 Price Target at TD Cowen - MarketBeat
UBS Lowers Molina Healthcare Price Target to $145 From $170, Maintains Neutral Rating - marketscreener.com
Molina Healthcare (MOH): Cantor Fitzgerald Maintains Neutral Rat - GuruFocus
Molina Healthcare Options Trading: A Deep Dive into Market Sentiment - Benzinga
Important Notice to Long-Term Shareholders of Molina Healthcare, Inc. (MOH): Grabar Law Office Investigates Claims on Your Behalf - TMX Newsfile
Molina Healthcare (NYSE:MOH) Price Target Lowered to $144.00 at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Adjusts Molina Healthcare Price Target to $144 From $180, Maintains Neutral Rating - marketscreener.com
Jefferies Adjusts Price Target on Molina Healthcare to $139 From $160, Maintains Hold Rating - marketscreener.com
What Molina’s Medicare Advantage exit says about the market - Modern Healthcare News
TD Cowen Adjusts Price Target on Molina Healthcare to $144 From $175, Maintains Hold Rating - marketscreener.com
Molina Healthcare Earnings Call: Growth Wins vs. Strain - TipRanks
Molina Healthcare, Coty, Illumina, Amazon and other big stocks moving lower in Friday's pre-market session - MSN
Molina Healthcare Loss Highlights Medicaid Risks And Potential Valuation Opportunity - Yahoo Finance
Molina Healthcare Crashed 26% on Earnings Disaster: Can the $187 Value Gap Close in 2026? - TIKR.com
Earnings Miss: Molina Healthcare, Inc. Missed EPS By 24% And Analysts Are Revising Their Forecasts - 富途牛牛
Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH) - The Globe and Mail
Molina Healthcare: Still Not Buying This Sick Puppy (NYSE:MOH) - Seeking Alpha
Molina Healthcare, Inc. (NYSE:MOH) Q4 2025 Earnings Call Transcript - Insider Monkey
Molina Healthcare Falls After Q4 Loss, Higher Medical Costs; Issues Muted 2026 Profit View - AlphaStreet News
Looking At The Narrative For Molina Healthcare (MOH) As Contracts And Policy Reset Expectations - Yahoo Finance
Molina Healthcare Q4 Earnings Call Highlights - MarketBeat
Molina Healthcare (MOH) Announces Amendments to Credit Agreement and Strategic Shift - GuruFocus
Molina Healthcare to record $93 million impairment, amends credit agreement - Investing.com
JP Morgan Reduces PT on Molina Healthcare (MOH) to $333 From $350, Keeps a Hold Rating - MSN
Molina Healthcare Announces Impairment Charge Amid Medicare Shift - TipRanks
Molina Healthcare Signs Credit Agreement Amendment With Truist Bank - TradingView
Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak. - Barron's
Molina Healthcare Inc (MOH) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing ... By GuruFocus - Investing.com Canada
Should You Buy the Dip in This Oversold Michael Burry Stock? - Yahoo Finance
Molina Healthcare stock dives 27% after 2026 profit outlook reset; Medicare Advantage exit looms - TechStock²
Molina Healthcare (MOH) Reports Q4 Loss, Secures Major Medicaid Contract - GuruFocus
Molina Healthcare Inc (MOH) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus
Molina Healthcare (MOH) Shares Plummet Over 28% - GuruFocus
Tech Bounces As Software Sell-Off Eases, Dow Jones Hits Records: What's Moving Markets Friday? - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Molina Healthcare Stock Falls 29%. Why Its Earnings Outlook Is So Bleak. - Barron's
Molina eyes acquisitions amid Medicare Advantage exit - Modern Healthcare News
Molina Healthcare's stocks fall as company plans exit from Medicare Advantage - Fierce Healthcare
Molina's Margin Trough Just Got Deeper - Morningstar
Molina Healthcare (MOH) Sees Significant Drop in Stock Value - GuruFocus
Molina Healthcare (NYSE:MOH) Hits New 12-Month Low After Earnings Miss - MarketBeat
Molina dips 26% on Q4 loss, weak outlook - breakingthenews.net
Molina Healthcare stock plunges after unexpected Q4 loss and weak 2026 outlook - MSN
Molina Drops After 2026 Profit Forecast Misses Expectations - Bloomberg.com
Earnings call transcript: Molina Healthcare’s Q4 2025 earnings miss shocks market - Investing.com India
Molina Healthcare Inc Stock (MOH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):